Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

India seeks to boost drug exports to semi regulated markets in Africa, Latin America, Southeast Asia

India monitoring pharma exports to China amid COVID surge: Source

Ruchika Sharma2 Jan 2023 12:12 PM IST

Bengaluru: India's Ministry of Commerce has been asked to monitor exports of medicinal products and equipment to China to ensure domestic availability...

Lumpy skin disease vaccine: Govt collaborates with Institute of Veterinary Biological Products for commercial production of Lumpi-ProVac

Ruchika Sharma2 Jan 2023 11:35 AM IST

Lumpi-ProVac is used for the prophylactic immunization of animals against lumpy skin disease which gives protection for about one year.

USFDA grants appeal for Ardelyx XPHOZAH

Ruchika Sharma1 Jan 2023 3:30 PM IST

XPHOZAH (tenapanor), discovered and developed by Ardelyx, is an investigational first-in-class phosphate absorption inhibitor (PAI).

MediWound bags USFDA nod for NexoBrid to treat severe thermal burns in adults

Ruchika Sharma1 Jan 2023 1:00 PM IST

NexoBrid (anacaulase-bcdb) is indicated for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns

Novavax begins Phase 2 trial for COVID-Influenza Combo, influenza stand-alone vaccines

Ruchika Sharma1 Jan 2023 11:30 AM IST

NVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.

AstraZeneca to Invest USD 15 Billion in China by 2030

AstraZeneca Calquence gets Japenese nod for treatment-naïve chronic lymphocytic leukaemia

Ruchika Sharma1 Jan 2023 10:00 AM IST

Calquence (acalabrutinib) is a next-generation, selective inhibitor of BTK.

Cough syrup crisis: Tamil Nadu suspends 2 drug inspectors, moves to close pharma co

Cough syrup deaths: Pharmexcil suspends membership of Marion Biotech

Ruchika Sharma31 Dec 2022 2:45 PM IST

"The incentives offered by the DoC (Department of Commerce) through Pharmexcil will not be extended until the suspension is revoked," sources told...

GSK, Sanofi, Pfizer and other drugmakers plan to raise prices on at least 350 drugs in US in January

Ruchika Sharma31 Dec 2022 1:15 PM IST

To date, Pfizer announced the most increases, with prices rising on 89 unique drug brands, and an additional increase on 10 drug brands at its Hospira...

Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer

Merck, Antengene collaborate to test Keytruda, ATG-037 combo for solid tumors in phase 1 trial

Ruchika Sharma31 Dec 2022 11:30 AM IST

ATG-037 is an orally available, small molecule CD73 inhibitor.

Pfizer Pentavalent Meningococcal Vaccine under USFDA review

Ruchika Sharma31 Dec 2022 10:00 AM IST

Pfizer’s MenABCWY vaccine candidate combines the components of two vaccines into one, helping protect against the meningococcal serogroups that cause...

Zydus Lifesciences bags USFDA nod for sleep disorder drug Triazolam

Ruchika Sharma30 Dec 2022 5:16 PM IST

Ahmedabad: Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has received final approval from the United States Food and...

Dr Mansukh Mandaviya reviews status of essential medicines with Pharma Companies

Ruchika Sharma30 Dec 2022 2:15 PM IST

The pharma companies were asked to keep a close watch on the global supply chain scenario.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok